The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1/2 study of devimistat in combination with hydroxychloroquine (HCQ) in patients with relapsed or refractory (R/R) clear cell sarcoma (CCS).
 
Mark Agulnik
Consulting or Advisory Role - Adaptimmune; AstraZeneca; Lilly; Regeneron
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Deciphera
Research Funding - Exelixis (Inst)
 
Elizabeth J. Davis
Honoraria - MJH Life Sciences
Consulting or Advisory Role - Deciphera
Speakers' Bureau - Physicans' Education Resource
Research Funding - Actuate Therapeutics (Inst); Bristol-Myers Squibb (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); Incyte (Inst); Karyopharm Therapeutics (Inst); TopAlliance BioSciences Inc (Inst)
 
Catherine M. Albert
No Relationships to Disclose
 
Lara E. Davis
Consulting or Advisory Role - Daiichi Sankyo
Research Funding - Bayer (Inst); BTG (Inst); Eisai (Inst); Novartis (Inst)
 
Timothy S. Pardee
Employment - Rafael Pharmaceuticals
Honoraria - Abbvie; Gentech; Karyopharm Therapeutics
Consulting or Advisory Role - Rafael Pharmaceuticals
Speakers' Bureau - Pharmacyclics
Research Funding - Karyopharm Therapeutics; Rafael Pharmaceuticals
 
Rashmi Chugh
Consulting or Advisory Role - Deciphera; Epizyme; Ipsen
Research Funding - AADi (Inst); Advenchen Laboratories (Inst); AstraZeneca (Inst); Ayala Pharmaceuticals; Epizyme (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Medivation (Inst); Mundipharma (Inst); Novartis (Inst); Plexxikon (Inst); Qilu Puget Sound Biotherapeutics (Inst); SpringWorks Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Wolters Kluwer
Expert Testimony - DOPF, PC; Meyers Law (Inst)
 
Matteo M. Trucco
No Relationships to Disclose